Non-invasive measurement of cerebral energy status: an opportunity to target neuroprotection in brain injury

ISRCTN ISRCTN84669284
DOI https://doi.org/10.1186/ISRCTN84669284
Protocol serial number 5789
Sponsor University College London Hospitals NHS Foundation Trust (UK)
Funders Engineering and Physical Sciences Research Council (EPSRC) (UK), Medical Research Council (MRC) (UK)
Submission date
12/05/2010
Registration date
12/05/2010
Last edited
12/05/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Injury, Occupational Diseases, Poisoning
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Martin Smith
Scientific

National Hospital for Neurology & Neurosurgery
Box 30
London
WC1N 3BG
United Kingdom

Study information

Primary study designObservational
Study designSingle centre non-randomised process of care trial
Secondary study designSingle-centre
Scientific title
Study acronymNon-invasive measurement of cerebral energy status
Study objectivesWe will use a combination of near infrared spectroscopy systems to assess non-invasively cerebral oxygenation, perfusion and cellular metabolic status in healthy volunteers and critically brain injured adults in order to monitor and quantify cerebral ischaemia in the latter. Specifically we will non-invasively measure changes in cell energy status by monitoring concentration changes in cytochrome oxidase (ox-CCO) using a novel hybrid optical spectroscopy system optimised for the measurement of ox-CCO in adults.
Ethics approval(s)MREC approved (ref: 04/Q0512/67)
Health condition(s) or problem(s) studiedTopic: Neurological; Subtopic: Neurological (all Subtopics); Disease: Nervous system disorders
InterventionVolunteer studies: Hyperoxia, hypoxia, hypercapnea and hypocapnea
Patient studies: NIRS-derived changes in cerebral oxygenation, haemodynamics and oxidised cytochorme c oxidase concentrations, and cerebral microdialysis-derived markers of ischaemia (lactate:pyruvate ratio and glucose).

Study entry: registration only
Intervention typeOther
Primary outcome measure(s)

Infrared specotrscopy

Key secondary outcome measure(s)

Estimated cerebal oxygen delivery

Completion date31/12/2011

Eligibility

Participant type(s)Healthy volunteer
Age groupAdult
Lower age limit18 Years
Sex
Target sample size at registration170
Key inclusion criteria1. Healthy volunteers and patients with severe traumatic brain injury
2. Male and female, lower age limit of 18 years
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/01/2006
Date of final enrolment31/12/2011

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

National Hospital for Neurology & Neurosurgery
London
WC1N 3BG
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summary
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/03/2008 Yes No